These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 38052016)

  • 41. Extended versus limited pelvic lymph node dissection during bilateral nerve-sparing radical prostatectomy and its effect on continence and erectile function recovery: long-term results and trifecta rates of a comparative analysis.
    Hatzichristodoulou G; Wagenpfeil S; Wagenpfeil G; Maurer T; Horn T; Herkommer K; Hegemann M; Gschwend JE; Kübler H
    World J Urol; 2016 Jun; 34(6):811-20. PubMed ID: 26420596
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The learning curve for laparoscopic extended pelvic lymphadenectomy for intermediate- and high-risk prostate cancer: implications for compliance with existing guidelines.
    Eden CG; Zacharakis E; Bott S
    BJU Int; 2013 Aug; 112(3):346-54. PubMed ID: 23419154
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Pelvic lymph node dissection during robot-assisted radical prostatectomy: efficacy, limitations, and complications-a systematic review of the literature.
    Ploussard G; Briganti A; de la Taille A; Haese A; Heidenreich A; Menon M; Sulser T; Tewari AK; Eastham JA
    Eur Urol; 2014 Jan; 65(1):7-16. PubMed ID: 23582879
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Surgeon-led prostate cancer lymph node staging: pathological outcomes stratified by robot-assisted dissection templates and patient selection.
    Altok M; Babaian K; Achim MF; Achim GC; Troncoso P; Matin SF; Chapin BF; Davis JW
    BJU Int; 2018 Jul; 122(1):66-75. PubMed ID: 29446205
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Cost-effectiveness comparison between neoadjuvant chemohormonal therapy and extended pelvic lymph node dissection in high-risk prostate cancer patients treated with radical prostatectomy: a multi-institutional analysis.
    Matsumoto T; Hatakeyama S; Ookubo T; Mitsuzuka K; Narita S; Inoue T; Yamashita S; Narita T; Koie T; Kawamura S; Tochigi T; Tsuchiya N; Habuchi T; Arai Y; Ohyama C
    Med Oncol; 2017 Oct; 34(12):190. PubMed ID: 29090390
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Validation and head-to-head comparison of three nomograms predicting probability of lymph node invasion of prostate cancer in patients undergoing extended and/or sentinel lymph node dissection.
    Grivas N; Wit E; Tillier C; van Muilekom E; Pos F; Winter A; van der Poel H
    Eur J Nucl Med Mol Imaging; 2017 Dec; 44(13):2213-2226. PubMed ID: 28780722
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Prospective Randomized Trial Comparing Titanium Clips to Bipolar Coagulation in Sealing Lymphatic Vessels During Pelvic Lymph Node Dissection at the Time of Robot-assisted Radical Prostatectomy.
    Grande P; Di Pierro GB; Mordasini L; Ferrari M; Würnschimmel C; Danuser H; Mattei A
    Eur Urol; 2017 Feb; 71(2):155-158. PubMed ID: 27544575
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Extended pelvic lymph node dissection including internal iliac packet should be performed during robot-assisted laparoscopic radical prostatectomy for high-risk prostate cancer.
    Jung JH; Seo JW; Lim MS; Lee JW; Chung BH; Hong SJ; Song JM; Rha KH
    J Laparoendosc Adv Surg Tech A; 2012 Oct; 22(8):785-90. PubMed ID: 22967037
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Extended pelvic lymphadenectomy for prostate cancer: will the previously reported benefits be reproduced in hospitals with lower surgical volumes?
    Lindberg C; Davidsson T; Gudjónsson S; Hilmarsson R; Liedberg F; Bratt O
    Scand J Urol Nephrol; 2009; 43(6):437-41. PubMed ID: 19707953
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Current status of pelvic lymph node dissection in prostate cancer.
    Aleksic I; Luthringer T; Mouraviev V; Albala DM
    J Robot Surg; 2014 Mar; 8(1):1-6. PubMed ID: 27637231
    [TBL] [Abstract][Full Text] [Related]  

  • 51.
    Ferraro DA; Muehlematter UJ; Garcia Schüler HI; Rupp NJ; Huellner M; Messerli M; Rüschoff JH; Ter Voert EEGW; Hermanns T; Burger IA
    Eur J Nucl Med Mol Imaging; 2020 Jan; 47(1):147-159. PubMed ID: 31522272
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Performance characteristics of computed tomography in detecting lymph node metastases in contemporary patients with prostate cancer treated with extended pelvic lymph node dissection.
    Briganti A; Abdollah F; Nini A; Suardi N; Gallina A; Capitanio U; Bianchi M; Tutolo M; Passoni NM; Salonia A; Colombo R; Freschi M; Rigatti P; Montorsi F
    Eur Urol; 2012 Jun; 61(6):1132-8. PubMed ID: 22099610
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Extended Pelvic Lymph Node Dissection Does Not Affect Functional Outcomes during Bilateral Nerve-Sparing Radical Prostatectomy.
    Krieger L; Holze S; Mende M; Do HM; Dietel A; Franz T; Arthanareeswaran VKA; Stolzenburg JU
    Urol Int; 2022; 106(11):1136-1144. PubMed ID: 36096125
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Effect of Peritoneal Fixation (PerFix) on Lymphocele Formation in Robot-assisted Radical Prostatectomy with Pelvic Lymphadenectomy: Results of a Randomized Prospective Trial.
    Student V; Tudos Z; Studentova Z; Cesak O; Studentova H; Repa V; Purova D; Student V
    Eur Urol; 2023 Feb; 83(2):154-162. PubMed ID: 36041934
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Complications of pelvic lymphadenectomy in clinically localised prostate cancer: different techniques in comparison and dependency on the number of removed lymph nodes].
    Winter A; Vogt C; Weckermann D; Wawroschek F
    Aktuelle Urol; 2011 May; 42(3):179-83. PubMed ID: 21409742
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Identification of the Optimal Candidates for Nodal Staging with Extended Pelvic Lymph Node Dissection Among Prostate Cancer Patients Who Underwent Preoperative Prostate-specific Membrane Antigen Positron Emission Tomography. External Validation of the Memorial Sloan Kettering Cancer Center and Briganti Nomograms and Development of a Novel Tool.
    Gandaglia G; Barletta F; Robesti D; Scuderi S; Rajwa P; Gomez Rivas J; Ibanez L; Soeterik TFW; Bianchi L; Afferi L; Kesch C; Darr C; Guo H; Zhuang J; Zattoni F; Fendler W; Marra G; Stabile A; Amparore D; Huebner NA; Giesen A; Joniau S; Schiavina R; Brunocilla E; Mattei A; Dal Moro F; Sierra JM; Porpiglia F; Picchio M; van den Bergh R; Shariat SF; Montorsi F; Briganti A
    Eur Urol Oncol; 2023 Dec; 6(6):543-552. PubMed ID: 37270378
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Extended pelvic lymph node dissection during robotic prostatectomy: antegrade versus retrograde technique.
    Albo G; Gallioli A; Ripa F; De Lorenzis E; Boeri L; Bebi C; Rocchini L; Longo F; Zanetti SP; Turetti M; Piccoli M; Montanari E
    BMC Urol; 2024 Mar; 24(1):64. PubMed ID: 38515053
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The impact of extended lymph node dissection versus neoadjuvant therapy with limited lymph node dissection on biochemical recurrence in high-risk prostate cancer patients treated with radical prostatectomy: a multi-institutional analysis.
    Narita T; Koie T; Ookubo T; Mitsuzuka K; Narita S; Yamamoto H; Inoue T; Hatakeyama S; Kawamura S; Tochigi T; Habuchi T; Arai Y; Ohyama C
    Med Oncol; 2017 Jan; 34(1):1. PubMed ID: 27889880
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Anatomical extent of pelvic lymphadenectomy in patients undergoing radical prostatectomy.
    Heidenreich A; Ohlmann CH; Polyakov S
    Eur Urol; 2007 Jul; 52(1):29-37. PubMed ID: 17448592
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Prospective Randomized Controlled Trial Exploring the Effect of TachoSil on Lymphocele Formation After Extended Pelvic Lymph Node Dissection in Prostate Cancer.
    Buelens S; Van Praet C; Poelaert F; Van Huele A; Decaestecker K; Lumen N
    Urology; 2018 Aug; 118():134-140. PubMed ID: 29775698
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.